Gentuity Partners with GE HealthCare to Enhance Access to Intravascular Imaging Solutions

Gentuity LLC has partnered with GE HealthCare to expand access to its advanced intravascular imaging platform. The collaboration aims to enhance availability, adoption, and functionality of imaging solutions for interventional cardiology through joint marketing and technical integration initiatives. GE HealthCare plans to explore opportunities to distribute Gentuity's products through its US distribution network, including the High-Frequency OCT Imaging System and Prime Micro-Imaging Catheter.

Gentuity LLC, a Massachusetts-based medical technology company specializing in next-generation intravascular imaging devices, has announced a collaboration with GE HealthCare. This strategic partnership aims to enhance the availability, adoption, and functionality of imaging solutions for interventional cardiology. The agreement, announced on Aug. 7, 2025, is expected to bring advanced imaging technologies to a broader range of healthcare providers [1].

Under the terms of the collaboration, Gentuity and GE HealthCare will jointly pursue co-marketing initiatives and technical integration of their respective technologies. Additionally, GE HealthCare plans to explore opportunities to expand access to Gentuity's innovative products through its own distribution network in the United States. The products to be distributed include the High-Frequency OCT Imaging System and the Prime Micro-Imaging Catheter [2].

The High-Frequency OCT Imaging System is a mobile console powered by machine learning technology, offering rapid setup and detailed imaging capabilities. The Vis-Rx® Prime Micro-Imaging Catheter is the world's smallest imaging catheter at 1.8F, designed for comprehensive vessel imaging before and after percutaneous coronary intervention (PCI) procedures [3].

Desmond Adler, President of Gentuity, expressed his enthusiasm about the partnership, stating, "We are thrilled at the opportunity to expand our relationship with GE HealthCare and look forward to bringing our advanced imaging solutions to a broader range of healthcare providers." He further emphasized that the collaboration is an important step in combining complementary technologies to amplify their individual impact [1].

Jyoti Gera, CEO of CardioVascular and Interventional Solutions at GE HealthCare, echoed this sentiment, noting that the collaboration supports their mission to enhance patient outcomes and quality of life through high-quality medical devices [1].

This agreement comes as Gentuity continues to build its reputation as a leader in advanced intravascular imaging technologies. The company's proprietary platform integrates artificial intelligence tools and user-centric design to reduce operator burden and improve procedural success [2].

The forward-looking statements in the announcement highlight potential risks and uncertainties, including the inability to achieve the anticipated benefits of the collaboration, business or commercial disruptions, and unexpected risks and liabilities [1].

References:
[1] https://www.prnewswire.com/news-releases/gentuity-llc-announces-agreement-to-collaborate-with-ge-healthcare-to-expand-access-to-advanced-intravascular-imaging-platform-302523606.html
[2] https://finance.yahoo.com/news/gentuity-llc-announces-agreement-collaborate-140000980.html
[3] https://www.newswise.com/articles/gentuity-llc-announces-agreement-to-collaborate-with-ge-healthcare-to-expand-access-to-advanced-intravascular-imaging-platform